TILT BIOTHERAPEUTICS
TILT Biotherapeutics is the leading company globally working in the area of enabling tumor T-cell therapy with oncolytic viruses. TILT is a preclinical stage company working in the field of cancer immunotherapy and will soon translate its unique approach into clinical trials. The company’s patented technology involves utilization of oncolytic viruses for enhancement of tumor T-cell therapy. Initial embodiments of the technology will be used to enhance tumor infiltrating lymphocyte (TIL), chimeric antigen receptor (CAR-T) and checkpoint inhibiting antibody therapy. The TILT approach has the potential to achieve similar results in CAR-T therapy of solid tumors as currently achieved for CD19+ hematological tumors.
TILT BIOTHERAPEUTICS
Industry:
Apps Biotechnology Health Care
Founded:
2013-01-01
Address:
Helsinki, Southern Finland, Finland
Country:
Finland
Website Url:
http://www.tiltbio.com
Total Employee:
1+
Status:
Active
Total Funding:
28.73 M EUR
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Apple Mobile Web Clips Icon Apache Sitelinks Search Box Microsoft Exchange Online
Current Advisors List
Current Employees Featured
Founder
Investors List
Lifeline Ventures
Lifeline Ventures investment in Venture Round - TILT Biotherapeutics
Tesi
Tesi investment in Venture Round - TILT Biotherapeutics
Business Finland
Business Finland investment in Grant - TILT Biotherapeutics
Business Finland
Business Finland investment in Venture Round - TILT Biotherapeutics
EASME - EU Executive Agency for SMEs
EASME - EU Executive Agency for SMEs investment in Grant - TILT Biotherapeutics
Business angels
Business angels investment in Seed Round - TILT Biotherapeutics
Lifeline Ventures
Lifeline Ventures investment in Seed Round - TILT Biotherapeutics
Business Finland
Business Finland investment in Seed Round - TILT Biotherapeutics
Keksintösäätiö
Keksintösäätiö investment in Seed Round - TILT Biotherapeutics
Horizon 2020
Horizon 2020 investment in Seed Round - TILT Biotherapeutics
Official Site Inspections
http://www.tiltbio.com
- Host name: grid1i.sigmatic.fi
- IP address: 80.69.161.45
- Location: Finland
- Latitude: 60.1717
- Longitude: 24.9349
- Timezone: Europe/Helsinki
More informations about "TILT Biotherapeutics" on Search Engine
TILT Biotherapeutics - Crunchbase Company Profile & Funding
TILT Biotherapeutics is the leading company globally working in the area of enabling tumor T-cell therapy with oncolytic viruses. TILT is a preclinical stage company working …See details»
TILT Biotherapeutics Presents Clinical Data on TILT-123 in …
HELSINKI, Finland, April 10, 2024 (GLOBE NEWSWIRE) -- TILT Biotherapeutics (TILT), a clinical-stage biotechnology company developing cancer immunotherapies presented …See details»
TILT Biotherapeutics Announces Positive Clinical Data on
Nov 6, 2023 TILT Biotherapeutics is a clinical-stage biotechnology company developing cancer therapeutics based on its proprietary oncolytic adenoviruses armed with …See details»
Next-generation armed oncolytic immunotherapies
TILT Biotherapeutics, a clinical-stage biopharma company, is developing a solution. TILT was founded on the unique discovery from clinical observations that oncolytic adenoviruses potently...See details»
TILT Biotherapeutics Announces Positive Update on its Phase 1 ...
Mar 31, 2022 TILT Biotherapeutics is a clinical-stage biotechnology company developing cancer therapeutics based on its proprietary oncolytic adenoviruses armed with …See details»
TILT Biotherapeutics Announces First US Patient …
Oct 11, 2022 TILT Biotherapeutics is a clinical-stage biotechnology company developing cancer therapeutics based on its proprietary oncolytic adenoviruses armed with molecules including cytokines that can...See details»
TILT Biotherapeutics Announces Positive Clinical Data on Lead …
HELSINKI, Finland, Nov. 06, 2023 (GLOBE NEWSWIRE) -- TILT Biotherapeutics (TILT), a clinical-stage biotechnology company at the forefront of developing cancer …See details»
TILT Biotherapeutics Announces Positive Clinical Data in …
HELSINKI, Finland, Dec. 08, 2023 (GLOBE NEWSWIRE) -- TILT Biotherapeutics (TILT), a clinical-stage biotechnology company at the forefront of developing cancer …See details»
TILT Biotherapeutics Announces over $10 Million Financing to …
Jun 14, 2022 TILT Biotherapeutics is a clinical-stage biotechnology company developing cancer therapeutics based on its proprietary oncolytic adenoviruses armed with …See details»
TILT Biotherapeutics Presents Clinical Data on TILT-123 in
Apr 10, 2024 TILT Biotherapeutics is a clinical-stage biotechnology company developing cancer therapeutics based on its proprietary oncolytic adenoviruses armed with …See details»
Unleashing the curative potential of cancer immunotherapy
Jul 25, 2022 TILT Biotherapeutics is developing a breakthrough oncolytic immunotherapy for treatment for cancer. Advanced solid tumors are currently incurable and limited …See details»
TILT Biotherapeutics Announces Positive Clinical Data in
HELSINKI, Finland, Dec. 08, 2023 (GLOBE NEWSWIRE) -- TILT Biotherapeutics (TILT), a clinical-stage biotechnology company at the forefront of developing cancer …See details»
TILT Biotherapeutics Reports Publication on its Oncolytic …
Aug 27, 2021 TILT Biotherapeutics is a clinical-stage biotechnology company developing cancer therapeutics based on its proprietary oncolytic adenoviruses armed with …See details»
TILT Biotherapeutics Announces First Patient Dosed in Phase
May 15, 2023 Tags. Biotechnology Cancer Oncology Clinical Trials Oncolytic Virus Cytokines. HELSINKI, Finland, May 15, 2023 (GLOBE NEWSWIRE) -- TILT …See details»
TILT Biotherapeutics Awarded USD 2M Grant from US …
HELSINKI, Finland, Feb. 14, 2024 (GLOBE NEWSWIRE) -- TILT Biotherapeutics (TILT), a clinical-stage biotechnology company developing cancer immunotherapies, announces it …See details»
TILT Biotherapeutics - Funding, Financials, Valuation & Investors
TILT Biotherapeutics has raised a total of. $48.1M. in funding over 9 rounds. Their latest funding was raised on Feb 14, 2024 from a Grant round. TILT Biotherapeutics is …See details»
TILT Biotherapeutics - Contacts, Employees, Board Members, …
About. TILT Biotherapeutics has 1 current employee profile, Founder & CEO Akseli Hemminki. TILT Biotherapeutics has 3 board members and advisors, including Timo …See details»
TILT Biotherapeutics - Tech Stack, Apps, Patents & Trademarks
Mar 10, 2024 About. TILT Biotherapeutics uses 13 technology products and services including HTML5 , jQuery , and Google Analytics, according to G2 Stack. TILT …See details»